Literature DB >> 6296818

Purified matrix protein of vesicular stomatitis virus blocks viral transcription in vitro.

B P De, G B Thornton, D Luk, A K Banerjee.   

Abstract

One of the major structural proteins of vesicular stomatitis virus is a small, nonglycosylated, matrix protein which associates with the nucleocapsid core during final stages of morphogenesis and budding. Biochemical and genetic studies suggested that the matrix protein regulates RNA synthesis both in vitro and in vivo. We have purified biologically active matrix protein from the virus and have directly shown that it significantly inhibits RNA synthesis in vitro mediated by the virion-associated RNA polymerase at low ionic strength (0.02 M). The inhibition was greater than 80% when the ratio of matrix protein to the major nucleocapsid protein in the transcribing complex was 2:1 (wt/wt). The inhibition was found to be at the level of RNA chain elongation and not at the initiation step. Electron microscopic studies revealed that inhibition of transcription by matrix protein was accompanied by a profound structural change of the transcribing nucleocapsid from an extended structure to a highly compact form. At higher ionic strength (0.12 M), the matrix protein failed to interact with the nucleocapsid. The matrix protein appears to be involved in condensing the nucleocapsid and blocking transcription during maturation of the virus particle.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6296818      PMCID: PMC347293          DOI: 10.1073/pnas.79.23.7137

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Complete nucleotide sequence of the leader RNA synthesized in vitro by vesicular stomatitis virus.

Authors:  R J Colonno; A K Banerjee
Journal:  Cell       Date:  1978-09       Impact factor: 41.582

2.  Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus.

Authors:  S U Emerson; Y Yu
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

3.  A routine method for protein-free spreading of double- and single-stranded nucleic acid molecules.

Authors:  H J Vollenweider; J M Sogo; T Koller
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

4.  The nature of the RNA products synthesized in vitro by subviral components of visicular stomatitis virus.

Authors:  G Abraham; A K Banerjee
Journal:  Virology       Date:  1976-05       Impact factor: 3.616

5.  Inhibitor of vesicular stomatitis virus transcriptase in purified virions.

Authors:  J Perrault; D T Kingsbury
Journal:  Nature       Date:  1974-03-01       Impact factor: 49.962

6.  Studies on the in vitro adenylation of RNA by vesicular stomatitis virus.

Authors:  A K Banerjee; S A Moyer; D P Rhodes
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

7.  The proteins of biologically active sub-units of vesicular stomatitis virus.

Authors:  B Cartwright; P Talbot; F Brown
Journal:  J Gen Virol       Date:  1970-06       Impact factor: 3.891

8.  The fine structure of vesicular stomatitis virus.

Authors:  T Nakai; A F Howatson
Journal:  Virology       Date:  1968-06       Impact factor: 3.616

9.  Structural components of vesicular stomatitis virus.

Authors:  R W Simpson; R E Hauser
Journal:  Virology       Date:  1966-08       Impact factor: 3.616

10.  Intracellular potassium and macromolecular synthesis in mammalian cells.

Authors:  M Lubin
Journal:  Nature       Date:  1967-02-04       Impact factor: 49.962

View more
  25 in total

1.  Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription.

Authors:  T Hoenen; N Biedenkopf; F Zielecki; S Jung; A Groseth; H Feldmann; S Becker
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

2.  Robust kinetics of an RNA virus: Transcription rates are set by genome levels.

Authors:  Collin Timm; Ankur Gupta; John Yin
Journal:  Biotechnol Bioeng       Date:  2015-05-20       Impact factor: 4.530

3.  Expression of the M gene of vesicular stomatitis virus cloned in various vaccinia virus vectors.

Authors:  Y Li; L Z Luo; R M Snyder; R R Wagner
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

4.  Monoclonal antibodies to the M protein of vesicular stomatitis virus (Indiana serotype) and to a cDNA M gene expression product.

Authors:  R Pal; B W Grinnell; R M Snyder; J R Wiener; W A Volk; R R Wagner
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

5.  Solubility of vesicular stomatitis virus M protein in the cytosol of infected cells or isolated from virions.

Authors:  B J McCreedy; K P McKinnon; D S Lyles
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

6.  Stereo images of vesicular stomatitis virus assembly.

Authors:  W F Odenwald; H Arnheiter; M Dubois-Dalcq; R A Lazzarini
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

7.  Mapping regions of the matrix protein of vesicular stomatitis virus which bind to ribonucleocapsids, liposomes, and monoclonal antibodies.

Authors:  J R Ogden; R Pal; R R Wagner
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

Review 8.  Transcription and replication of rhabdoviruses.

Authors:  A K Banerjee
Journal:  Microbiol Rev       Date:  1987-03

9.  Glycoprotein-dependent acidification of vesicular stomatitis virus enhances release of matrix protein.

Authors:  Chad E Mire; Derek Dube; Sue E Delos; Judith M White; Michael A Whitt
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

10.  Rabies virus M protein expressed in Escherichia coli and its regulatory role in virion-associated transcriptase activity.

Authors:  Y Ito; A Nishizono; K Mannen; K Hiramatsu; K Mifune
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.